Updated:
Pharmaceutic Litho & Label Co.
Pharmaceutic Litho & Label Co. is a Simi Valley, California-based single-family office managing wealth from pharmaceutical printing and labeling.
Pharmaceutic Litho & Label Co.
Founded in an undisclosed year, Pharmaceutic Litho & Label Co. functions as a single-family office rooted in the industrial sector. The firm's name implies the underlying wealth originated from a business providing lithographic printing and labeling services for pharmaceutical companies. No public information identifies the founding family or current principals. The office appears to focus on capital preservation, likely allocating across real estate, private credit, and healthcare services. Direct investments are not publicly documented, but the structure suggests a preference for tangible assets and income-generating strategies. Geographic focus remains domestic, centered on the United States. No team size, additional offices, or deployment figures are disclosed. No operational events from the last 24 months are publicly available. The office's key structural differentiator is its likely origin in a niche industrial product — pharmaceutical labeling — a high-margin, specialized business that provided durable cash flows. This legacy may influence a conservative, asset-backed investment approach.
General information
Firm type
Single Family Office
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Simi Valley
Corporate office
Simi Valley, CA, United States
Sector focus
Frequently asked questions
Who runs investment decisions at Pharmaceutic Litho & Label Co.?
No named principals or investment professionals are publicly disclosed. The firm may be managed directly by the founding family or a small internal team. External advisors may support capital allocation decisions.
How does Pharmaceutic Litho & Label Co. source proprietary deal flow?
The firm does not publicly describe its sourcing methods. Given its private nature, deal flow likely comes through family networks, existing banking relationships, and opportunistic direct approaches rather than a formal investment team.
Is Pharmaceutic Litho & Label Co. structured as a single family office or does it operate more like a venture firm?
The structure is consistent with a single-family office focused on wealth management for a single family, not a venture firm. There is no evidence of outside LP capital or external fund vehicles.
Does Pharmaceutic Litho & Label Co. participate in fund commitments or only direct deals?
No public information specifies whether the office invests through funds or direct deals. Its private structure suggests a mix may be used, but no commitments or direct holdings are disclosed.
What investment stages does Pharmaceutic Litho & Label Co. typically target?
Target stage is not publicly documented. Given the firm's probable conservative posture, it likely focuses on mature, cash-flow-generating assets in sectors like real estate and private credit rather than early-stage venture.
Where does the underlying wealth come from?
The firm's name indicates wealth originated from a business in pharmaceutical lithographic printing and labeling. This is a specialized industrial niche that could generate stable, long-term cash flows.
Does Pharmaceutic Litho & Label Co. maintain philanthropic structures, and how are they separated?
No public information exists about philanthropic structures. If present, they would typically be managed separately from investment operations but cannot be confirmed.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: